RUSH Heme/Onc refresher of Taha Alrifai presentation last September!

Another triple therapy to choose from in mHSPC! PEACE-1 or ARASENS Revathi Kollipara Ami Dave Taha Alrifai How will you choose? RUSH Heme/Onc

Great multi disciplinary case-based presentation at today’s medical grand rounds of a patient with HIV+/HHV8+ multicentric Castleman disease who presented with fevers and AMS, thrombocytopenia, diffuse LAD, and ARF. Amazing recovery of plt count with weekly rituximab.

What’s new in myeloma? 1/ Frontline treatment: We are recommending quadruplets as initial therapy for more patients, especially as pre transplant induction for high risk myeloma. My preferred quadruplet is Dara-VRd.

Presenters include our very own Shivi Jain!

1st Annual Sickle Cell Disease Consortium October 8,2022 . Saturday. Inperson event. Venue: Crowne Plaza, West loop Chicago Honored to have Dr. Kanter as our Keynote spekaer and Dr. Carroll as our distinguished speaker.SCDAI Rush University RUSH Cancer Center @RushIMChiefs

Please joins us and shine light on SCD SCDAI SCDAA 1st Annual Sickle Cell Disease Consortium October 8,2022 . Saturday. Inperson event. Venue: Crowne Plaza, West loop Chicago Speakers: Dr. Julie Kanter, Dr. Patrick Carroll Registration:free! urldefense.com/v3/__http:/www…

Dr. Shivi Jain from Rush University Medical Center speaking at the first Sickle Cell Consortium meeting that she has organized at Chicago today along with her esteemed colleagues.